Retatrutide is a new pharmaceutical in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in investigations. By activating these receptors, https://lewyswslv423434.bligblogging.com/36838601/tirzepatide-a-promising-new-treatment-for-obesity